CARE Ratings Limited has informed the Exchange that Board of Directors at its meeting held on May 12, 2025, recommended Final Dividend of 11 per equity share.
CARERATING · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.8 pts more than Nifty Microcap 250 and 12.2 pts more than its Capital Markets peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
CARE Ratings' Board of Directors, at its meeting on May 12, 2025, approved the audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with B S R & Co. LLP issuing an unmodified audit opinion. The Board also recommended a final dividend of Rs. 11 per equity share (face value Rs. 10) for FY25, taking the total dividend to Rs. 18 per share for the year (including Rs. 7 interim already paid in Q2 FY25). On the consolidated front, revenue from operations grew about 21% to Rs. 40,232 lakhs, while net profit rose roughly 36% to Rs. 14,000 lakhs; standalone net profit stood at Rs. 14,799 lakhs. The company appointed Parikh & Associates as Secretarial Auditor for a five-year term (FY 2025-26 to FY 2029-30), subject to shareholder approval. The record date for the dividend is June 27, 2025, and the 32nd AGM is scheduled for July 10, 2025.
Shareholders will receive a higher total dividend this year (Rs. 18 vs Rs. 15 in FY24), reflecting stronger FY25 earnings, which is a positive signal for income-seeking investors. The clean audit, healthy profit growth, and steady dividend may support investor sentiment around the stock.